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 The period of development between the zygote and embryonic day 9.5 in mice includes 
multiple developmental milestones essential for embryogenesis. The preeminence of this 
period of development has been illustrated in loss of function studies conducted by the 
International Mouse Phenotyping Consortium (IMPC) which have shown that close to one third 
of all mouse genes are essential for survival to weaning age and a significant number of 
mutations cause embryo lethality before E9.5. Here we report a systematic analysis of 21 pre-
E9.5 lethal lines generated by the IMPC. Analysis of pre- and post-implantation embryos 
revealed that the majority of the lines exhibit mutant phenotypes that fall within a window of 
development between implantation and gastrulation with few pre-implantation and no post-
gastrulation phenotypes. Our study provides multiple genetic inroads into the molecular 
mechanisms that control early mammalian development and the etiology of human disease, in 
particular, the genetic bases of infertility and pregnancy loss.  We propose a strategy for an 
efficient assessment of early embryonic lethal mutations that can be used to assign 
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 The period of development between the zygote and the pharyngula stage at embryonic 
day 9.5 (E9.5) encompasses multiple developmental milestones that are essential for survival 
of the embryo to term. These include cleavage, blastocyst formation, implantation, axial 
specification, gastrulation and establishment of the anlagen of multiple organ systems (Kojima 
et al., 2014; Rivera-Perez, 2013). This is also the time when crucial events like zygote genome 
activation (Jukam et al., 2017; Sha et al., 2019; Svoboda et al., 2015; Tadros and Lipshitz, 
2009; Vastenhouw et al., 2019) and X-chromosome inactivation (Deng et al., 2014; Galupa 
and Heard, 2018) occur. In addition, this is the period of development when totipotent and 
pluripotent cells are allocated to specific pathways of differentiation. For example, segregation 
of trophoblast, epiblast and primitive endoderm lineages takes place between the 4th and 6th 
cell divisions (Kojima et al., 2014; Morris et al., 2010; Rossant, 2016, 2018). The prominence 
of the early stages of embryogenesis in human gestation is underscored by clinical studies 
indicating that 30% of human conceptions are lost before the embryo implants in the uterine 
wall (Macklon et al., 2002; Moore and Persaud, 2003). Moreover, measurements of chorionic 
gonadotropin, a marker of implantation, show that an additional 30% of pregnancies are lost 
shortly after implantation (Macklon et al., 2002). Clinical studies have also shown that the risk 
of early pregnancy loss increases with delayed implantation (Wilcox et al., 1999).  
 In mice, the significance of the early stages of development for mammalian 
embryogenesis has been unveiled in loss of function studies conducted by the International 
Mouse Phenotyping Consortium (IMPC). The IMPC is a global coalition of research institutions 
that aims to generate and characterize 20,000 individual knockout mouse lines 
(www.mousephenotype.org). A pivotal outcome of the IMPC efforts is that close to one third of 
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all mouse genes are essential for survival to weaning age (Dickinson et al., 2016). Moreover, 
analysis of 242 lethal lines showed that the majority of these mutations (60.7%) are lethal 
before E12.5 and a large percentage of these pre-E12.5 lethal mutations (72.8%), have 
ceased development before E9.5 (Dickinson et al., 2016). Therefore, understanding the 
causes of embryo lethality at pre-E9.5 stages can provide a plethora of information on the 
genes that play key roles in early embryogenesis and about the developmental constraints that 
are responsible for the etiology of pregnancy loss and developmental abnormalities. 
 In this study, we aimed to elucidate the morphological anomalies of pre-E9.5 lethal lines 
that prevent zygote advancement through the onset of organogenesis, specifically, to assign 
phenotypes to developmental milestones and outline the time of lethality. Because of the 
possibility of maternal rescue (Bultman et al., 2006; Dodge et al., 2004; Jedrusik et al., 2015; 
Kim et al., 2016; Li et al., 2010), we hypothesized that the majority of the lethal phenotypes 
would become evident after the blastocyst stage (E3.5). As expected, only a few of the lines 
analyzed showed phenotypes that were evident at the blastocyst or earlier stages (4/21) while 
the majority of the mutant embryos (17/21) showed phenotypes between implantation and 
gastrulation. Intriguingly, no mutants were found to undergo normal gastrulation and reach 
early organogenesis stages. 
 These results indicate that the majority of embryonic lethal phenotypes taking place 
before E9.5 fall between implantation and gastrulation and suggests that maternal components 
may rescue pre-implantation phenotypes. The absence of post-gastrulation mutant phenotypes 
may reflect previous detection of this class of mutations in phenotypic screens conducted at 
E9.5 by the IMPC and suggests that mutant embryos that can undergo gastrulation, will 
survive to E9.5 or later stages. 
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 We propose that an effective way to narrow down the phenotype of early lethal mouse 
lines should include an assessment of embryos at E9.5 to detect post-gastrulation 
abnormalities and a subsequent analysis of embryos at E3.5 to segregate lines with pre-
implantation and post-implantation phenotypes. These latter phenotypes will fall between E3.5 
and E7.5, a period of development encompassing implantation, egg cylinder formation, axial 
specification and gastrulation. Further analysis at these stages should delineate the phenotype 
in more detail. This strategy can outline the phenotype of early developmental mutants and 
guide future avenues of mammalian research. 
 
Results 
Pre-E9.5 mutant embryos show abnormalities at gastrulation or earlier stages.  
 A total of 21 knockout lines containing pre-E9.5 lethal alleles were obtained from IMPC 
centers (Supp. Table 1). Each line was chosen randomly to avoid bias in specific molecular, 
cellular or developmental processes.  We began with an assessment of E7.5 embryos derived 
from heterozygous crosses (Fig. 1A). We chose this period of development because at this 
time, the embryos have reached gastrulation stages and are relatively easy to assess 
morphologically under a dissecting microscope.  For each litter, we documented the number of 
decidua and resorption sites. Lines that did not produce mutant embryos at E7.5 were 
assessed at blastocyst stages (E3.5) and some of them were subjected to embryo explant 
assays to determine the phenotype in more detail. We also analyzed mutant embryos at E2.5 
for the lines that did not produce mutants at E3.5 (Fig. 1A). 
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 In our initial assessment at E7.5, we recovered mutant embryos from 7 lines: Chmp3, 
Cog7, Kti12, Prpf40a, Ptcd3, Tmed10, and Ubiad1, whereas the rest of the lines produced 
empty deciduae, deciduae containing remnants of resorbing embryos or did not leave any 
traces of mutant embryos (Table 1). 
 
 














Embryo Genotyping 2  
P value 
Mut Het Wt 
 Alg11tm1.1 6 1 37 30a 8 0 21 9 0.00293 
 Aurkaip1em1 5 2 30 31a 0 0 19 12 0.00436 
 Chmp3tm1b 7 2 47 38 9 8 20 10 0.85394 
 Cog7tm1b 6 1 38 35 3 9 19 7 0.78438 
 ExoC2em1 5 0 50 40 10 0 24 16 0.00075 
 Kti12tm1.1 10 6 32 28 4 6 18 4 0.27645 
 Nup153em1 3 0 35 31 4 0 15 16 0.00026 
 Orc1tm1b 5 0 47 31 16 0 23 8 0.00337 
 Pibf1tm1.1 7 0 48 43 5 0 35 8 0.00005 
 Prpf40aem1 10 6 33 29 4 3 22 4 0.01996 
 Ptcd3tm1.1 6 1 44 40 4 8 22 10 0.74082 
Psmc6tm1b 8 3 31 30a 2 0 24 6 0.00136 
 Rfc1tm1b 7 3 40 33 7 0 22 11 0.00409 
 Rgp1tm1.1 7 1 56 35b 21 0 25 9 0.00214 
 Snrnp27tm1b 4 0 35 30 5 0 21 9 0.0061 
 Srbdem1 8 3 45 30 15 0 22 8 0.00452 
 Srp9tm1.1 7 2 40 28 12 0 21 7 0.00525 
 Stx18tm2b 10 4 54 42b 12 0 32 9 0.00026 
 Tmed10tm1.1 8 3 34 31 3 3 22 6 0.04899 
 Tomm20em1 8 2 55 36a 20 0 27 9 0.00117 
 Ubiad1em1 6 3 30 29 1 8 15 6 0.85627 
aTwo embryos were found in the same decidua.  
bOne embryo lost, not genotyped.  
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 These results indicate that all the lines analyzed have phenotypes that are evident at 
gastrulation or at earlier stages and that mutant embryos from two thirds of the lines (14/21) do 
not reach gastrulation. Interestingly, we did not observe mutant embryos with normal 
gastrulation that would indicate a post-gastrulation phenotype. 
 
Mutant embryos recovered at E7.5 have peri-gastrulation defects. 
 The phenotypes of mutant embryos that survived to E7.5 varied from line to line but 
were fully penetrant. Mutant embryos can be classified into 5 categories: abnormal 
gastrulation, absence of primitive streak, developmental delay, extra-embryonic tissue 
abnormalities and gross morphological malformations. 
 Embryos exhibiting gastrulation defects were the most developmentally advanced. They 
initiated gastrulation, as indicated by the presence of the primitive streak, but had gastrulation 
abnormalities (Fig. 1B-D). Cog7tm1b mutant embryos were smaller than littermates and 
appeared to have advanced to mid-streak stage (Fig. 1B). The posterior amniotic fold was 
present in some mutants but did not fuse with the anterior amniotic fold to form the amnion. 
Similarly, Tmed10tm1.1 mutants were smaller than littermates and had reached a stage close to 
mid-streak, but contrary to Cog7tm1 mutant embryos, did not show evidence of the posterior 
amniotic fold, suggesting an earlier gastrulation phenotype (Fig. 1C).  Kti12tm1.1 mutants 
showed only an incipient primitive streak and were significantly smaller than littermates, 
reaching only about one third of the proximodistal length of the egg cylinder shown by controls 
(Fig. 1D). 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted October 8, 2020. . https://doi.org/10.1101/2020.10.08.331587doi: bioRxiv preprint 
 8 
  
Figure 1. Analysis of Pre-
E9.5 Lethal lines at E7.5.  
A. Schematic representation 
of the strategy utilized to 
assess the phenotype of 
mutant embryos. Embryos 
derived from heterozygous 
crosses were initially 
assessed at E7.5. For lines 
in which no homozygous 
mutants were recovered at 
E7.5, we analyzed embryos 
at E3.5 and those that did 
not produce mutant embryos 
at E3.5, were assessed at 
E2.5.  Explant culture 
assays of E3.5 embryos 
were used to assess their 
ability to hatch and to form 
embryo outgrowths. B-H. 
Images from lines that 
produced mutant embryos 
that survived to E7.5. Mutant 
embryos (M), heterozygous 
(H) and wild-type embryos 
(W) are indicated. Arrows in 
E indicate the location of a 
constriction at the boundary 
between the epiblast and the 
extra-embryonic ectoderm 
observed in Ubiad1em1 
mutant embryos. Arrow in G, 
indicates visceral endoderm 
bulges present in Chmp3tm1b 
mutant embryos. Scale bars, 
200 m. 
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Mutants for Ubiad1em1 did not show evidence of a primitive streak (Fig. 1E). They had a 
cylindrical epiblast morphology as opposed to an oblong cylinder shape, indicating elongation 
along the anteroposterior axis. A clear constriction was evident at the boundary between the 
epiblast and extra-embryonic ectoderm (Fig. 1E). Ubiad1em1 mutants were in general smaller 
than control littermates but some of them were of similar or larger size. 
 Ptcd3tm1.1 mutants were significantly smaller than control littermates, spanning 
approximately one quarter of the length of the proximo-distal axis of the egg cylinder of control 
embryos (Fig. 1F). There was no evidence of primitive streak formation and their small size 
and relative normal morphology was reminiscent of ~E6.0 embryos, suggesting developmental 
delay.  
 Chmp3tm1b mutants showed extra-embryonic abnormalities. They were smaller than 
littermate controls and had a very characteristic phenotype consisting of bulging visceral 
endoderm cells (Fig. 1G). The most severe phenotype at E7.5 was observed in Prpf40aem1 
mutants. These embryos consisted of small amorphous pieces of tissue surrounded by 
maternal components that were close to complete resorption (Fig. 1H). 
 In summary, mutant embryos that survived to E7.5 have a variety of peri-gastrulation 
abnormalities which suggest that attainment of gastrulation is a major barrier for subsequent 
embryo development. 
 
The majority of the mutant embryos survive to E3.5. 
 Our initial analysis revealed that two thirds of the mutant lines (14/21) did not generate 
mutant embryos that survived to E7.5 (Table 1). To further characterize the phenotype of 
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these lines, we analyzed embryos at E3.5. At this time of development, embryos range from 
compacted morulae to expanded blastocysts. This analysis allowed us to assess embryo 
survival during pre-implantation stages and to narrow the window of lethality. 
 With the exception of Nup153em1 and Pibf1tm1.1, twelve lines generated mutant embryos 
that survived to E3.5 (Table 2). A few Nup153em1 (1/27) and Pibf1tm1.1 (2/27) mutant embryos 
were obtained at E2.5 (Table 2), suggesting a requirement for these genes at cleavage or 
earlier stages. 












Embryo Genotyping 2  
P value 
Mut Het Wt 
Alg11tm1.1 5 0 36 E3.5 11 17 8 0.73671 
Aurkaip1em1 7 0 47 E3.5 7 31 9 0.04244 
ExoC2em1 6 1 35 E3.5 4 19 12 0.14126 
Nup153em1 5 1 29 E3.5 0 22 7 0.00381 
Nup153em1 4 1 27 E2.5 1 20 6 0.01733 
Orc1tm1b 4 0 31 E3.5 5 15 11 0.30807 
Pibf1tm1.1 7 0 50 E3.5 0 37 13 0.00011 
Pibf1tm1.1 3 0 27 E2.5 2 18 7 0.08840 
Psmc6tm1b 11 2 45 E3.5 10 29 6 0.10717 
Rfc1tm1b 5 0 27 E3.5 3 19 5 0.09173 
Rgp1tm1.1 4 1 28 E3.5 8 13 7 0.89840 
Snrnp27tm1b 15 6 70 E3.5 16 41 13 0.31438 
Srbdem1 6 1 39 E3.5 8 25 6 0.96227 
Srp9tm1.1 6 2 26 E3.5 6 13 7 0.28105 
Stx18tm2b 4 0 29 E3.5 3 21 5 0.04728 
Tomm20em1 4 0 30 E3.5 8 15 7 0.96722 
 
 Analysis of embryo morphology revealed abnormal development of Srbd1em1 and 
Snrnp27tm1b mutant embryos at E3.5. Srbd1em1 mutants gave rise to globular structures that 
resembled compacted morulae and contained cellular debris in the periphery (Fig. 2A). 
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Snrnp27tm1b mutants were at a compacted morula or early blastocyst stages and none had 
reached an expanded blastocyst stage (Fig. 2B), suggesting delayed development. The rest of 
the lines (10/12) did not show abnormal morphology at E3.5. 
 These results indicate that most of the embryos that do not survive to E7.5 can undergo 
cleavage and survive to E3.5, hence, the majority of the pre-E9.5 mutant lines have lethal 
phenotypes between E3.5 and E7.5, a period of development that encompass implantation 
and gastrulation. 
  
Explant culture experiments reveal hatching and abnormal growth phenotypes 
 To characterize further the phenotype of mutant embryos that survived to E3.5, we 
conducted explant culture assays. Explanted embryos grown in ES cell media hatch from the 
zona pellucida and generate outgrowths composed of trophectodermal cells attached to the 
bottom of the plate and a centrally located group of cells derived from the inner cell mass (Fig. 
2C). Using this assay, we were able to evaluate mutant embryos from five lines: Srbd1em1, 
Snrnp27tm1b and Psmc6tm1.1, Alg11tm1.1 and Tomm20em1.  
 Srbd1em1, Snrnp27tm1b and Psmc6tm1.1 mutant embryos failed to hatch (Fig. 2D-F). After 
four days in culture, these embryos were still enclosed by the zona pellucida and had a 
globular morphology, suggestive of arrested development. Srbd1em1 explants had large 
vesicles that got more pronounced as the embryo degenerated further (Fig. 2D). Snrnp27tm1b 
mutants appeared darkened with cellular debris in the periphery (Fig. 2E) and Psmc6tm1.1 
mutants seem to be fragmenting (Fig. 2F). 
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 Hatching defects were also observed in explant cultures of Alg11tm1.1 mutant embryos, 
although there were signs of partial hatching that included zona pellucida erosion or partial 
extrusion of the embryo (Fig. 2G, H).  Only one Alg11tm1.1 embryo managed to hatch but cells 
formed small clumps of degenerating cells (not shown).  
Figure 2. Characterization of pre-gastrulation lethal lines at E3.5. A and B. Litters recovered from 
Srbdem1 (A) and Snrnp27tm1b (B) heterozygous crosses. Mutant embryos (M), heterozygous (H) and wild-
type embryos (W) are indicated. Srbdem1 mutant embryos have cellular debris in the periphery. Snrnp27tm1b 
mutant embryos were less developed than control littermates. C. Image of control blastocyst outgrowth 
cultured for four days. The outgrowth consists of an inner cell mass (ICM) derivative located in the center 
of the outgrowth and trophectoderm (TE) derivatives in the periphery. D-H. Explant cultures showing 
Srbd1em1 (D), Snrnp27tm1b (E), Psmc6tm1.1 (F) and Alg11tm1.1 (G, H) mutant embryos that failed to hatch. 
Large vacuoles in Srbd1em1 embryos are indicated by black arrows. In Alg11tm1.1 mutants, zona erosion 
and partial extrusion of embryo is evident (arrows).  I and J. Tomm20em1 mutant explants hatched, but 
failed to develop further in explant culture, forming hollow vesicles that were similar to blastocysts (I) or 
that produced underdeveloped outgrowths with poor trophectoderm development (J). Scale bars, 50 m. 
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 Tomm20em1 mutant embryos were able to hatch, and in some cases, attached to the 
bottom of the plate but generated underdeveloped outgrowths with poor trophectodermal 
component (Fig. 2I, J). 
 These experiments suggest that mutations in these genes disrupt trophectoderm 




 Our understanding of the genetic mechanisms that control development in mice has 
traditionally relied on a heterogeneous multipronged analysis of naturally occurring mutations 
as well as assessment of mutant mice generated using gene targeting strategies (Eppig et al., 
2015). However, a systematic approach to characterize mouse phenotypes is highly valuable 
since the analysis of mouse mutations underpins our understanding of mammalian gene 
function and of genes linked to human disease (de Angelis et al., 2015; Dickinson et al., 2016). 
In this study, we analyzed pre-E9.5 lethal lines that emphasize the inactivation of a critical 
exon or complete deletion of a gene to ensure a full knockout 
(www.mousephenotype.org/understand/the-data/allele-design/). This approach together with a 
rigorous maintenance of the lines in a C57Bl/6NJ genetic background, allowed an earnest 
comparison of the phenotypes obtained. Our goal was to assign phenotypes to developmental 
milestones of early embryogenesis and outline the time of lethality.  
 We analyzed 21 knockout lines that were randomly chosen from IMPC repositories. 
Analysis of these lines at E7.5 revealed that only one third (7/21) produced mutant embryos 
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that survived the first week of embryogenesis.  The mutant embryos showed a variety of peri-
gastrulation abnormalities that included delayed development, gastrulation defects and extra-
embryonic tissue anomalies. This suggests that attainment of gastrulation is a major hurdle 
during embryogenesis.  Intriguingly, there were no mutant embryos that looked 
morphologically normal at E7.5 or that had completed gastrulation, as indicated by the 
elevation of the neural folds, a sign of the onset of organogenesis. One possible explanation 
for this observation is that mutant embryos with post-gastrulation phenotypes were able to 
survive to E9.5 and that they were excluded from the pool of pre-E9.5 lethal lines by previous 
E9.5 phenotype screens conducted by the IMPC (Dickinson et al., 2016). Alternatively, it is 
possible that they occur at low frequency and they were not detected in our study. 
 E3.5 analysis of the lines that did not generate mutant embryos at E7.5 revealed that 
mutant embryos from most of the lines advanced to the blastocyst stage. We, however, were 
not able to recover Nup153em1 and Pibf1tm1.1 mutants at E3.5. Instead, a reduced number of 
null embryos were obtained at the 8-cell stage (E2.5). These results suggest a requirement for 
these genes in oogenesis, fertilization or cleavage stages. Two lines, Srbd1em1 and 
Snrnp27tm1b, generated embryos at E3.5 that were distinguished by morphology or delayed in 
development, respectively. Nonetheless, the fact that most of the lines reached the blastocyst 
stage suggests that some mutant phenotypes were rescued throughout the pre-implantation 
period by maternal components supplied by the oocyte. This is a phenomenon that has been 
reported previously in mutants for Brg1, Eset, Cdx2 and Setdb1 (Bultman et al., 2000; Bultman 
et al., 2006; Dodge et al., 2004; Jedrusik et al., 2015; Kim et al., 2016). Analysis of maternal 
mutations should reveal the functional requirement for these genes in pre-implantation 
development. 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted October 8, 2020. . https://doi.org/10.1101/2020.10.08.331587doi: bioRxiv preprint 
 15 
 Embryo explant assays conducted in five lines, revealed that four of them had hatching 
defects and one was able to hatch but showed poor trophectoderm growth. Hatching defects 
and poor trophectodermal growth in these embryos suggest abnormal trophectoderm function 
since this tissue controls hatching and implantation (Perona and Wassarman, 1986; Russ et 
al., 2000; Schiewe et al., 1995; Strumpf et al., 2005; Wang and Dey, 2006), which in turn, can 
lead to implantation failure or lethality soon afterwards. 
 Overall, our results indicate that the majority of pre-E9.5 lethal strains generate mutant 
embryos that can survive to the blastocyst or later stages of development up to gastrulation. In 
figure 3, we illustrate these results relative to the time of gestation and key events of 
embryogenesis. 
Figure 3. Approximate onset of lethal phenotypes relative to developmental landmarks. Mutant embryos 
exhibit a variety of phenotypes that span pre-implantation and gastrulation stages (E2.5-E7.5). The majority of 
the mutations (19/21) affected stages between the blastocyst stage and gastrulation (E3.5-E7.5). Mutants for 
genes marked in blue had normal blastocyst morphology but were not able to develop to E7.5, suggesting lethality 
between implantation and pre-gastrulation stages (E4.0-E6.5). For simplicity, the parietal yolk sac is not depicted 
in conceptuses from E5.25 onwards. ICM, inner cell mass (yellow); Epi, epiblast (blue); AVE, anterior visceral 
endoderm (green); PS, primitive streak (red) and PYS, parietal yolk sac.  
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 Our data shows that about 50% of the lines studied (11/21) can implant and continue 
development over a post-implantation window of time that precedes the onset of gastrulation 
(~E4.0 - ~E6.5). These lines may have phenotypes that affect the formation of the egg 
cylinder, the process of axial specification or have defects that prevent them from advancing to 
gastrulation. Kojima and co-workers have suggested that attainment of a threshold number of 
cells has a strong correlation with formation of the proamniotic cavity in the epiblast and 
attainment of gastrulation (Kojima et al., 2014). This is based on blastomere reduction 
experiments (Power and Tam, 1993; Rands, 1986), however, analysis of tetraploid embryos 
which have half the cell number but increased cell volume due to hyperploidy reach 
gastrulation at the same time as diploid embryos (Henery et al., 1992). Therefore, it is 
suggested that the beginning of gastrulation may be related to tissue size not just cell number 
(Kojima et al., 2014). In the case of early post-implantation lethal lines, it is possible that 
mutations that lead to low cell numbers at pre-gastrulation stages will not reach the critical cell 
number to allow proper morphogenesis of the epiblast or reach the critical tissue mass to 
initiate gastrulation. 
 The majority of the lines for which mutant embryos were absent at E7.5, produced 
resorption sites that consisted of empty decidua or decidua that contained debris of resorbing 
embryos. These included lines with cleavage phenotypes like Nup153em1 and Pibf1tm1.1 for 
which no mutant embryos were observed at E3.5. This suggest that some pre-implantation 
lethal embryos can survive to post-implantation stages. However, an alternative explanation is 
that resorptions obtained from these lines represent heterozygous or wild-type embryos that 
perished after implantation. This is also the case of Snrnp27tm1b embryos who were delayed in 
development at E3.5 and failed to hatch in explant culture experiments. 
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 The frequency of resorption sites appeared to correlate with the severity of the 
phenotype. The number of resorptions amounted to 10%, 11% and 14% in Nup153em1, 
Pibf1tm1.1 and Snrnp27tm1b mutant lines respectively, which had the earliest phenotypes. In 
contrast, analysis of litters from Alg11tm1.1 and Tomm20em1, which had less severe phenotypes, 
revealed higher proportion of resorption sites that amounted to 22% and 36%, respectively. 
This suggests that the most severely affected mutants perish earlier in development and traces 
of the embryos or remnants of implantation, do not last to E7.5. An exception was Srbd1em1 
mutants which led to abnormal blastocysts morphology and failed to hatch in explant culture 
assays, yet generated resorption sites at a frequency of 33%. These results suggest that the 
uterus provides a more favorable environment for embryo survival than in vitro culture 
conditions. 
 The data presented here, should be viewed as the starting point for future experiments 
that can shed light on the mechanisms of early mammalian development as well as inform us 
on the etiology of human disease. It has been postulated that a clock mechanism controlling 
pre-implantation development may be linked to titration of inhibitory cytoplasmic factors or 
mechanism associated with DNA replication, DNA modification and chromatin remodeling 
(Kojima et al., 2014). Thus, analysis of phenotypes with pre-implantation lethality and 
subsequent transcriptional profiling can define molecular pathways and reveal candidates that 
mediate cleavage and the transition through compaction and blastocyst formation. Current 
models suggest that a cell sorting mechanism driving the segregation of epiblast and primitive 
endoderm cells begins in the ICM of E3.5 blastocysts (Chazaud and Rossant, 2006; Plusa et 
al., 2008). Phenotypes affecting this process will be reflected in the formation of the primitive 
endoderm which can be revealed by markers of primitive endoderm such as Pdgfr (Artus et 
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al., 2010). Analysis of Nanog and Gata6 in the ICM will also shed light on this phenomenon 
(Frum et al., 2013; Rossant, 2016; Schrode et al., 2013).  
 Some lines showed a high proportion of plugged females that were not pregnant. These 
lines include Kti12tm1.1 and Prpf40aem1 in which 6 out of 10 plugged females did not produce 
embryos. These results suggest uterine anomalies or other defects indicative of limited fertility 
in heterozygous animals. This is an exciting possibility that can inform human fertility research 
since almost a quarter of clinical infertility cases in humans are idiopathic (Matzuk and Lamb, 
2002). Further studies will be necessary to confirm these results and determine if anatomical 
defects, gonadal dysfunction, endocrinopathies or other defects are responsible for these 
fertility abnormalities (Matzuk and Lamb, 2002). 
 Biological systems have an inherent ability to maintain phenotypic stability shaped by 
evolution that allows them to thrive in an unpredictable environment (de Visser et al., 2003). 
Phenotypic stability, defined as the ability of a biological system to maintain its functions 
despite internal and external perturbations, is known as robustness (Kitano, 2004; Stelling et 
al., 2004). Robustness may explain the survival of 66% of the mutant lines generated by the 
IMPC that are homozygous viable and another 9.6% that are subviable 
(https://www.mousephenotype.org/data/embryo). In fact, evidence suggests that subviable 
lines are more likely to have a paralog gene than lethal ones (Dickinson et al., 2016). In 
zebrafish, genetic robustness has been proposed to occur by a process of compensation 
called transcriptional adaptation in which mutant mRNA degradation triggers the upregulation 
of genes that exhibit sequence similarity to the mutated gene (El-Brolosy et al., 2019; El-
Brolosy and Stainier, 2017). Expression profiling of mutant and control embryos will allow us to 
explore these possibilities.  
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted October 8, 2020. . https://doi.org/10.1101/2020.10.08.331587doi: bioRxiv preprint 
 19 
 As previously mentioned, the IMPC plans to generate and functionally characterize 
mutations in 20,000 mouse genes and expects that a significant proportion of the mutated 
genes will have lethal phenotypes during early embryogenesis 
(www.mousephenotype.org/about-impc/). Therefore, an efficient strategy will have to be 
employed to functionally annotate these lethal phenotypes. Our study indicates that the 
majority of pre-E9.5 lethal lines exhibit phenotypes that fall within a window of development 
between implantation and gastrulation (E4.0 and E7.5) with a few pre-implantation and no 
post-gastrulation phenotypes. Hence, an efficient strategy to narrow down the phenotype of 
lethal mutations occurring at early stages of embryogenesis is to analyze embryos at E9.5 to 
detect post-gastrulation phenotypes and at E3.5 to segregate pre- and post-implantation 
phenotypes. Further analysis at E7.5 (or E6.75) should help distinguish phenotypes occurring 
at pre-gastrulation or during gastrulation stages. Additional analyses at other stages and 
blastocyst explant culture experiments combined with expression profiling should help pinpoint 
the molecular and cellular mechanisms driving the phenotypes observed. 
 
Acknowledgements 
We thank Zdenka Matijasevic for critically reading the manuscript. This work was supported by 
NIH grant HD083311 to JAR-P. 
 
Authors Contributions 
YY, dissected E7.5 embryos, conducted analysis of mutant phenotypes, performed embryo 
explant experiments, analyzed results and wrote the manuscript together with JAR-P; JR, 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted October 8, 2020. . https://doi.org/10.1101/2020.10.08.331587doi: bioRxiv preprint 
 20 
Conducted analysis of mutant phenotypes, performed embryo explant experiments, gathered 
results, maintained mouse colony, genotyped embryos and mice; JG and PX conducted in 
vitro fertilization experiments; JAR-P, conceived and planned the experiments, dissected E7.5 
embryos, analyzed data, wrote the manuscript. 
 
Declarations of Interests 
The authors declare no competing interests. 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted October 8, 2020. . https://doi.org/10.1101/2020.10.08.331587doi: bioRxiv preprint 
 21 
Materials and Methods 
 
Mice 
All experiments were conducted under the guidance of the Institutional Animal Care and Use 
Committee of the University of Massachusetts Medical School.  Live heterozygous mice or 
frozen sperm from mutant lines were obtained from repositories at the Jackson Laboratory, 
Baylor college of Medicine or the University of California-Davis (Supplementary Table 1). All 
mice were maintained in C57BL/6NJ background. To generate additional heterozygous 
animals, founder mice were mated to wild-type C57Bl/6JN mice. Frozen sperm was used to 
fertilize oocytes obtained from C57Bl/6JN females as described below. Animals were 
maintained on a 12 h light cycle. The mid-point of the light cycle of the day that a mating plug 
was observed was considered embryonic day 0.5 (E0.5) of gestation. 
 
In vitro fertilization 
Females were superovulated using a HyperOva (anti-inhibin antisera) and hCG combination, 
as previously described (Nakagawa et al., 2016; Takeo and Nakagata, 2015). In vitro 
fertilization was conducted with a recently described method that leads to high fertilization 
rates from shipped cryopreserved sperm (Nakagata et al., 2014; Takeo and Nakagata, 2018). 
This procedure allowed us to generate large cohorts of heterozygous animals of similar age to 
simultaneously generate multiple embryos for phenotype analysis. 
 
Embryo staging 
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Conceptuses were staged using morphological landmarks as described by Downs and Davis 
(Downs and Davies, 1993) and Rivera-Perez and co-workers (Rivera-Perez et al., 2010). 
Cleavage stage embryos were staged by counting the number of blastomeres. Blastocysts 
were staged using the ratio of polar to mural trophectoderm based on the description of 
Gardner (Gardner, 1997) using the following classification: very early blastocyst (3:1), early 
blastocyst (2:1), expanding blastocyst (1:1) and expanded blastocyst (1:2 or more). 
 
Explant culture assays 
Embryos were collected from uteri of pregnant females at E3.5 as previously described 
(Behringer et al., 2014). Litters were imaged using an inverted fluorescence microscope 
(Leica, DMI4000). To generate outgrowths, each embryo was cultured in individual drops of 
DMEM containing 10% FBS for 4-7 days in a tissue culture incubator supplemented with 5% 
CO2 and 5% O2. 
 
Isolation and analysis of E7.5 embryos 
E7.5 embryos were dissected as follows: heterozygous females mated with heterozygous 
males were euthanized by cervical dislocation. The uterine horns were removed, placed in 
PBS and each implantation site was dissected manually using forceps to isolate the decidua. 
The shape and size of each decidua was assessed to detect potential anomalies that could 
indicate the presence of abnormal embryos. Decidua were then transferred to DMEM media 
containing 20 mM HEPES. Each decidua was split longitudinally to access the embryos 
(Behringer et al., 2014). At this time, the parietal yolk sac was assessed for the presence of 
debris or blood infiltration that may indicate abnormal function or defective embryos. After 
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removal of the parietal yolk sac, the shape and the length of the proximodistal axis of the egg 
cylinder (from the base of the ectoplacental cone to the tip of the epiblast) was evaluated 
visually and compared with littermates.  
  
Genotyping 
 The genotype of mice and E7.5, E3.5 and E2.5 embryos was determined by PCR using 
the oligos described in Supplementary Table 2. Mouse tails (2 mm tail tip piece) were placed in 
200 l of PCR lysis buffer (50 mM KCl, 10 mM Tris-HCl pH8.3, 2.5 mM MgCl2, 0.1 mg/ml 
gelatin, 0.45% IGEPAL and 0.45% Tween 20) containing 100 mg/ml Proteinase K and 
incubated overnight at 56oC. After lysis, the proteinase K was inactivated at 95oC for 8 min and 
0.5 - 1 l of the sample was used for the PCR reaction. E7.5 embryos were lysed in 20 l and 
E3.5 and E2.5 embryos in 10 l of PCR lysis buffer. The ectoplacental cone of E7.5 embryos 
was removed before PCR analysis to avoid maternal contamination. 
 
Statistical Analysis 
The statistical significance of embryo frequencies obtained from heterozygous crosses was 
assessed using Chi-Square test (d.f.=2,  0.05). We assessed a minimum of 26 or 28 embryos 
per line at E3.5 and E7.5 respectively. 
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Supplementary Table 1. E9.5 Lethal Lines Analyzed  
Gene / Allele Gene Name  
Chrom. 
Location 
Line Name Source 
Alg11tm1.1 
Asparagine-linked glycosylation 11 
(alpha-1,2-mannosyltransferase)  
8 B6N(Cg)-Alg11tm1.1(KOMP)Vlcg/J JAX 









Component of oligomeric Golgi complex 
7  
7 B6N(Cg)-Cog7tm1b(EUCOMM)Hmgu/J JAX 
ExoC2em1 Exocyst Complex Component 2 6 B6NJ-ExoC2em1(IMPC)J/Mmjax JAX 
Kti12tm1.1 KTI12 homolog, chromatin associated 4 B6N(Cg)-Kti12tm1.1(KOMP)Vlcg/J JAX 
Nup153em1 Nucleoporin 153 6 B6NJ-Nup153em1(IMPC)J/Mmjax JAX 
Orc1tm1b Origin recognition complex, subunit 1 4 B6N(Cg)-Orc1tm1b(KOMP)Wtsi/J JAX 
Pibf1tm1.1 
Progesterone Immunomodulatory 
Binding Factor 1 
14 B6N(Cg)-Pibf1tm1.1(KOMP)Vlcg/J JAX 
 Prpf40aem1 
Pre-mRNA Processing Factor 40 
Homolog A 
2 B6NJ-Prpf40aem1(IMPC)J/Mmjax JAX 
Psmc6tm1b Proteasome 26S Subunit, ATPase 6 14 B6NJ-Psmc6tm1b(KOMP)Wtsi/J JAX 
Ptcd3tm1.1 Pentatricopeptide repeat domain 3 6 B6N(Cg)-Ptcd3tm1.1(KOMP)Vlcg/J JAX 
Rfc1tm1b Replication Factor C Subunit 1 10 B6N(Cg)-Rfc1tm1b(KOMP)Mbp/J JAX 
Rgp1tm1.1 RAB6A GEF complex partner 1 4 B6N(Cg)-Rgp1tm1.1(KOMP)Vlcg/J JAX 
Snrnp27tm1b 
Small Nuclear Ribonucleoprotein 





Srbdem1 S1 RNA Binding Domain 1 2 B6NJ-Srbd1em1(IMPC)J/Mmjax JAX 
Srp9tm1.1 Signal recognition particle 9 1 B6N(Cg)-Srp9tm1.1(KOMP)Vlcg/J JAX 
Stx18tm2b Syntaxin 18 5 B6N(Cg)-Stx18tm2b(KOMP)Wtsi/J JAX 
Tmed10tm1.1 
Transmembrane P24 Trafficking Protein 
10 
12 B6N(Cg)-Tmed10tm1.1(KOMP)Vlcg/J UC-Davis 
Tomm20em1 
Translocase of Outer Mitochondrial 
Membrane 20 
1 B6NJ-Tomm20em1(IMPC)J/Mmjax JAX 
Ubiad1em1 
UbiA Prenyltransferase Domain 
Containing 1 
1 B6NJ-Ubiad1em1(IMPC)J/Mmjax JAX 
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Supplementary Table 2. List of oligos used for genotyping  
Allele Oligo Name Oligo Sequence 
Alg11tm1.1 
LacZ Common F 5'-GGTCGCTACCATTACCAGTTG-3' 
Alg11 Mut R 5'-ACTCCCACACACGAAGCAC-3' 
Alg11 Wt F 5'-CCACCTTGTGATGTGCAGAC-3' 
Alg11 Wt R 5'-CTCACCAATCCCAAAATGCT-3' 
Aurkaip1em1 
Aurkaip1 Common F 5'-GTAGGGACAGGATTTGCGCT-3' 
Aurkaip1 Mut R 5'-TAGATCTTCGGGGTCTGCCA-3' 
Aurkaip1 Wt R 5'-GGCAGGAACGACTGAAACCT-3' 
Chmp3tm1b 
LacZ Common F 5'-GGTCGCTACCATTACCAGTTG-3' 
Common R 5'-AGAGAAGCAGAGGTGAGTGG-3' 
Chmp3 Wt F 5'-GATGAAGGTGACTGGGCTAG-3' 
Cog7tm1b 
LacZ Common F 5'-GGTCGCTACCATTACCAGTTG-3' 
Cog7 Mut R 5'-GGGACAGCTGGAGAACAACT-3' 
Cog7 Wt F 5'-ACCTGCTTCTGCTCCACTGT-3' 
Cog7 Wt R 5'-TGACCCAAGACCAACAAAAAG-3' 
ExoC2em1 
ExoC2 Mut F 5'-GTGAAATCCTAAACCAAAAAGTGT-3' 
ExoC2 Common R 5'-TTATCTGTGAAACCACTGACTGAAGC-3' 
ExoC2 Wt F 5'-TTATGTTCTTGAAGTGGAGGGATTC-3' 
Kti12tm1.1 
Kti12 Mut F 5'-CGGTCGCTACCATTACCAGT-3' 
Kti12 Common R 5'-CGAGTCAAAACTTGGCCATC-3' 
Kti12 Wt F 5'-TCTCAGCCTCTAGCCTCTGG-3' 
Nup153em1 
Nup153 Common F 5'-AAGATCCAGAAGGATGAA-3' 
Nup153 Mut R 5'-GAACTTCATTCCAAATGTTCCA-3' 
Nup153 Wt R 5'-CACAACTGTTTCCAGCAAAATTAC-3' 
Orc1tm1b 
Orc1 Mut F 5'-CGGTCGCTACCATTACCAGT-3' 
Orc1 Mut R 5'-GCCAGGTCAGACCAGTCTCT-3' 
Orc1 Wt F 5'-CCCGTGTCTACAACTCCAAC-3' 
Orc1 Wt R 5'-CCAGGCTGTCCTAGAATTGG-3' 
Pibf1tm1.1 
Pibf1 Mut F 5'-CGGTCGCTACCATTACCAGT-3' 
Pibf1 Mut R 5'-TTCCCAGAGACCACTTCTGC-3' 
Pibf1 Wt F 5'-GGAAACCATTTTATTGCGACAG-3' 
Pibf1 Wt R 5'-CAGGAATAGAGAGTTGATCTTCAGG-3' 
Prpf40aem1 
Prpf40a Common F 5'-CGACTCCAGTGTTGATGAGC-3' 
Prpf40a Mut R 5'-GTTAACCATTTAAGAGTGAGGATGG-3' 
Prpf40a Wt R 5'-AACAATGCAATGTAAATCAGTTTC-3' 
Psmc6tm1b 
Psmc6 Mut F 5'-CGGTCGCTACCATTACCAGT-3' 
Psmc6 Mut R 5'-AGTCTCGACCCTCATTATGCTG-3' 
Psmc6 Wt F 5'-AGAAGACTTGGTTTTCACCACA-3' 
Psmc6 Wt R 5'-GATGCCCTCTTCTGATGTGT-3' 
Ptcd3tm1.1 
Ptcd3 Mut F 5'-CGGTCGCTACCATTACCAGT-3' 
Ptcd3 Mut R 5'-GGATCCCAGCCCTGTATCTG-3' 
Ptcd3 Wt F 5'-GCCAGAGGTGCTCTAAGTGG-3' 
Ptcd3 Wt R 5'-TGGACACTTCAGCTCTCACC-3' 
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Supplementary Table 2. List of oligos used for genotyping (continued) 
Allele Oligo Name Oligo Sequence 
Rfc1tm1b 
Rfc1 Mut F 5'-CGGTCGCTACCATTACCAGT-3' 
Rfc1 Mut R 5'-GCCTCCTATTCACAGAACTTCA-3' 
Rfc1 Wt F 5'-CAGCCTTCCGTTTTTCAGAC-3' 
Rfc1 Wt R 5'-CTCACAGAACGCAGTCTCCA-3' 
Rgp1tm1.1 
Rgp1 Mut F 5'-CGGTCGCTACCATTACCAGT-3' 
Rgp1 Mut R 5'-GCTGCCAACTTCCTCCAAAG-3' 
Rgp1 Wt F 5'-GGGCCAGTGTATCCTTTCTACT-3' 
Rgp1 Wt R 5'-CTCCGTGGGCAGCACTTC-3' 
Snrnp27tm1b 
Snrnp27 Mut F 5'-GTCAGTATCGGCGGAATTCCAGCTG-3' 
Snrnp27 Common R 5'-CCTAAATCAAAACATACACTGGACACTCAC-3' 
Snrnp27 Wt F 5'-GTTGGATAAGCAGACTTATCTAGTTAATTTCAG-3' 
Srbdem1 
Srbd1 Common F 5'-GCCACTGGGTTCTCTTCTGA-3' 
Srbd1 Mut R 5'-ACACATGTCTTCGACCCAAATG-3' 
Srbd1 Wt R 5'-GAAATGCCATAGAGGGGAGA-3' 
Srp9tm1.1 
Srp9 Mut F 5'-CGCTCGCTACCATTACCAGT-3' 
Srp9 Mut R 5'-TTCCTCGGCTTTGACAGCTC-3' 
Srp9 Wt F 5'-GCCCTAGTAGCTATCCTGGAA-3' 
Srp9 Wt R 5'-TGGGACGCATGCACCTAGT-3' 
Stx18tm2b 
Stx18 Mut F 5'-CGGTCGCTACCATTACCAGT-3' 
Stx18 Mut R 5'-ATACCGTTCCACCCTTAGCC-3' 
Stx18 Wt F 5'-GGAGCCAGGTGCTCTGTACT-3' 
Stx18 Wt R 5'-GCAAGCCACTCACCCTACA-3' 
Tmed10tm1.1 
Tmed10 Mut F 5'-GCAGCCTCTGTTCCACATACACTTCA-3' 
Tmed10 Mut R 5'-GGCTGGCTTTGGCGTTATCTAGG-3' 
Tmed10 Wt F 5'-CCTTGGAAGGGCAGAGTTCTGC-3' 
Tmed10 Wt R 5'-GTCACAGCCAACGTTATTGTCTGC-3' 
Tomm20em1 
Tomm20 Mut F 5'-AGAGAAAGATCCTACCTAGAAACACCA-3' 
Tomm20 Com R 5'-TGGTTCTTTTGCTACTGTGCTG-3' 
Tomm20 Wt F 5'-TGATTGGATTTTCCTTTCTTCC-3' 
Ubiad1em1 
Ubiad1 Common F 5'-GAACCTTTTGCATGTTCTTGG-3' 
Ubiad1 Mut R 5'-CCATCAACCCTGGTCAAACT-3' 
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